오메가3 부작용 문제 결국 또 터졌다! 이제 이렇게 오메가3 권하고 싶습니다(오메가3 부정맥의 진실, 안전하게 섭취하는 방법)

1. 오메가 3 부작용에 대한 논의가 심방세동 위험과 관련하여 떠오르고, 유럽 의약품 청의 결정을 토대로 식약처가 해당 제품에 부정맥 경고를 추가하는 명령을 내렸다. 이에 대한 현명한 오메가 3 복용 방법과 실제 팩트에 대한 검토를 진행한다.

The discussion on the side effects of Omega-3 has emerged, particularly concerning the increased risk of atrial fibrillation. Following the decision of the European Medicines Agency, the Korean Food and Drug Administration issued an order to add a warning about arrhythmia to 94 Omega-3 products. This prompts a thoughtful exploration of how to wisely consume Omega-3 and an examination of the actual facts.

 

2. 오메가 3에 대한 연구가 많이 이뤄진 영양소이지만, 유럽 의약품 청이 리드 스이나 스트랭스 등 대규모 임상 논문을 근거로 심방세동 부작용을 추가하기로 결정한 것을 소개한다. 그러나 최근 연구 중에서도 4g 이하의 적은 용량에서는 부정맥 위험을 증가시키지 않았다는 결론이 나오고 있음을 강조한다.

Although Omega-3 is a heavily researched nutrient, the European Medicines Agency decided to include arrhythmia as a side effect based on large-scale clinical studies. However, recent studies indicate that in doses below 4g, the risk of arrhythmia does not increase.

 

3. 심방세동 부작용에 대한 연구 중에서 7.4년 동안 당뇨병 환자에게 Omega-3를 투여한 결과와 다른 연구들을 소개한다. 그 중 일부는 심방세동 위험을 높이지 않았으며, 통계적으로 유의미하지 않은 결과도 존재한다.

Studies on the side effects of arrhythmia include results from administering Omega-3 to diabetic patients for 7.4 years, as well as other studies showing no significant increase in the risk of arrhythmia, both statistically and clinically.

 

4. 하버드 대학의 연구에서는 13년간 4,000명 이상을 추적한 결과, Omega-3 섭취로 심방세동 위험률이 오히려 7%에서 133% 감소했다고 소개한다. 이로 인해 현재의 상황에서도 부정맥 위험 증가에 대한 논의가 복잡하다는 점을 강조한다.

A Harvard University study tracking over 4,000 individuals for 13 years suggests a decrease in the risk of arrhythmia with Omega-3 intake, complicating the ongoing discussion about the increased risk of arrhythmia.

 

5. 결론적으로, 오메가 3 섭취량에 따른 심방세동 위험을 정확히 평가하기 위해 주의가 필요하며, 현재까지 4g 이하의 용량에서는 명백한 부정맥 위험 증가 근거가 없다. 그러나 높은 용량에서는 신중한 섭취가 필요하며, 식약처의 권장 섭취량을 고려하여 적절한 용량을 선택하는 것이 중요하다.

In conclusion, caution is needed to accurately assess the risk of arrhythmia based on Omega-3 intake. There is no clear evidence of increased arrhythmia risk with doses below 4g. However, careful consumption is necessary at higher doses, and choosing an appropriate dosage considering the recommended intake by regulatory authorities is crucial.